Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 113

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1A
Chunk 113
---
In addition to the other information contained in this Annual Report and the exhibits hereto, you should carefully consider the risks described below. These risks are not the only ones that we may face. Additional risks not presently known to us or that we currently consider immaterial may also impair our business operations. This Annual Report also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks faced by us described below or elsewhere in this Annual Report. Investing in our common stock involves a high degree of risk and if any of these risks or uncertainties occur, the trading price of our common stock could decline, and you could lose part or all of your investment. 

Risks Related to our Merger with SeaSpine

Although we have made significant progress in integrating the SeaSpine business, the remainder of our integration activities may not be completed smoothly or successfully, and we may not achieve all of the anticipated benefits of the merger.

While we have successfully completed many integration activities since the closing of merger, the remainder of our integration activities may not be completed smoothly or successfully. We may face challenges in completing remaining integration activities, which could result in delays, increased costs, decreases in the amount of expected revenues, and other adverse impacts, which could materially affect our financial position, results of operations, and cash flows. In addition, the integration of certain operations requires the dedication of significant management resources, which may temporarily distract management’s attention from our day-to-day business. Employee uncertainty and lack of focus during the integration process may also disrupt our business. 

Our future results may be adversely impacted if we do not effectively manage our complex operations resulting from the merger.

As a result of the merger, the size of our business has become significantly larger. Our ability to successfully manage this expanded business depends, in part, upon our ability to design and implement strategic initiatives that address not only the integration of the SeaSpine business, but also the increased scale and scope of the combined business with its associated increased costs and complexity. There can be no assurances that we will be successful in integrating the business or that we will realize the expected operating efficiencies, cost savings, and other benefits as originally anticipated from the merger.

We have incurred substantial expenses related to the merger and we expect to incur substantial additional integration expenses.

We incurred substantial expenses in connection with the completion of the merger and we have incurred substantial expenses related to integration activities performed to date in order to integrate a large number of processes,